Subscribe To
Opgen announces closing of $7.5 million public offering
ROCKVILLE, Md., Jan. 11, 2023 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), a precision medicine company harnessi...
January 11, 2023, 9:30 pm
Cathie wood makes this molecular diagnostics company top holding of ark invest's flagship fund, catapulting past zoom, tesla
Shares of Exact Sciences, Inc. EXAS have been on a tear, having gained over 27% in two sessions this week....
January 11, 2023, 11:19 am
Danaher (dhr) provides improved q4 core revenue growth guidance
Benefiting from strong growth in Cepheid's molecular diagnostics among other factors, Danaher (DHR) imp...
January 10, 2023, 2:18 pm
Kronos bio's stock rallies after announcing drug-discovery deal with roche
Shares of Kronos Bio Inc. KRON, +2.38% jumped 25% in premarket trading on Monday after the company announced a development deal with Roche Holding's R...
January 9, 2023, 8:23 am
molecular partners provides updates at 41st annual jpm healthcare conference
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Jan. 08, 2023 (GLOBE NEWSWIRE) — Ad hoc announcement pursuant to Art. 53 LR : ...
January 8, 2023, 8:00 pm
Opgen announces pricing of $7.5 million public offering
ROCKVILLE, Md., Jan. 06, 2023 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), a precision medicine company harnessi...
January 7, 2023, 1:00 am
moleculin to present at the virtual investor 2023 companies to watch event
Live video webcast on Tuesday, January 17 th at 9:00 AM ET HOUSTON, Jan. 5, 2023 /PRNewswire/ -- mole...
January 5, 2023, 8:45 am
Revolutionizing protein sequencing: quantum-si's single-molecule technology
Quantum-Si's technology has potential in drug discovery and biomarker test development. The company's Platinum sequencing platform is set to launch....
January 4, 2023, 6:53 pm
4d molecular therapeutics: another gene therapy player with a differentiated profile
FDMT is an undercovered gene therapy developer. It claims certain competitive differences for its vector delivery platform....
January 3, 2023, 8:55 am
Ultra-high molecular weight polyethylene (uhmwpe) market size to surpass usd 3.4 billion by 2028 at 9.5% cagr – report by market research future (mrfr)
Ultra-High molecular Weight Polyethylene (UHMWPE) Market Insights and Industry Analysis by Form (Sheets...
January 2, 2023, 11:00 am
molecular partners to present at 41st annual jp morgan healthcare conference and swiss investor conferences
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Dec. 30, 2022 (GLOBE NEWSWIRE) — molecular Partners...
December 30, 2022, 6:00 am
molecular partners to present at 41st annual jp morgan healthcare conference and swiss investor conferences
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Dec. 30, 2022 (GLOBE NEWSWIRE) -- molecular Partners ...
December 30, 2022, 1:00 am
Htg molecular diagnostics provides highlights of its second event in drug discovery kol webcast series
TUCSON, Ariz., Dec. 28, 2022 (GLOBE NEWSWIRE) -- HTG molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), ...
December 28, 2022, 8:00 am
Terns announces closing of public offering of shares of common stock, including full exercise of underwriters’ option to purchase additional shares
FOSTER CITY, Calif., Dec. 23, 2022 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stag...
December 23, 2022, 9:05 pm
Htg molecular diagnostics announces closing of a $10 million public offering
TUCSON, Ariz., Dec. 23, 2022 (GLOBE NEWSWIRE) — HTG molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG),...
December 23, 2022, 9:05 pm
Retirement weekly: don’t play whack-a-mole with your retirement investments
All types of investments will occasionally lag a reasonable benchmark. Read Full Story The post Retirement Weekly: Don’t play whack-a-...
December 23, 2022, 7:05 pm
Applied molecular transport announces top-line phase 2 results from lombard monotherapy trial of oral amt-101 in patients with moderate-to-severe ulcerative colitis
– Similar clinical remission rates observed in patients receiving AMT-101 monotherapy compared to placebo at week 12 – AMT-101 was well-tolerated ...
December 22, 2022, 10:30 pm
89bio: let's not give up already
ETNB went down after Madrigal's success. It has a NASH molecule with a different mechanism of action....
December 22, 2022, 8:34 am
Angion receives nasdaq notice regarding minimum bid price requirements
UNIONDALE, N.Y., Dec. 21, 2022 (GLOBE NEWSWIRE) — Angion Biomedica Corp (NASDAQ:ANGN), a biopharmaceutical company that has focused on the discovery...
December 22, 2022, 2:50 am
Htg molecular diagnostics announces pricing of a $10 million public offering
TUCSON, Ariz., Dec. 21, 2022 (GLOBE NEWSWIRE) — HTG molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG),...
December 21, 2022, 6:15 pm